Published in J Alzheimers Dis on January 01, 2012
Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease. Stem Cells Transl Med (2016) 0.81
Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease. PLoS One (2013) 0.80
The Possible Roles of the Dentate Granule Cell's Leptin and Other Ciliary Receptors in Alzheimer's Neuropathology. Cells (2015) 0.75
Cell encapsulation: promise and progress. Nat Med (2003) 2.18
[Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology]. Enferm Infecc Microbiol Clin (2005) 2.05
Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy (2013) 1.80
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials (2007) 1.77
New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol (2006) 1.72
Shedding light in the controversial terminology for platelet rich products. J Biomed Mater Res A (2009) 1.54
A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy (2012) 1.51
Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. J Control Release (2009) 1.48
Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med (2009) 1.46
Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain. Enferm Infecc Microbiol Clin (2011) 1.44
Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A (2006) 1.43
Rigorous methodology is the school of coherent conclusions in science. Eur J Oral Implantol (2013) 1.41
Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. Biomaterials (2006) 1.41
The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study. Dermatol Surg (2017) 1.37
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature. Biochim Biophys Acta (2005) 1.36
Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging (2007) 1.35
Microcapsules and microcarriers for in situ cell delivery. Adv Drug Deliv Rev (2010) 1.33
Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research. Clin Transl Oncol (2012) 1.32
Cell microencapsulation technology: towards clinical application. J Control Release (2008) 1.26
Role of insulin-like growth factor I signaling in neurodegenerative diseases. J Mol Med (Berl) (2003) 1.22
Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci (2009) 1.22
Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater (2008) 1.20
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation (2012) 1.15
Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol (2005) 1.14
Drug delivery in biotechnology: present and future. Curr Opin Biotechnol (2003) 1.13
Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials (2009) 1.11
A biological approach to orthopaedic surgery: are they lost in translation? Arthroscopy (2013) 1.08
Delivering growth factors for therapeutics. Trends Pharmacol Sci (2007) 1.07
Platelet-rich plasma and myofibroblasts: is the composition the key to success? Adv Skin Wound Care (2015) 1.07
Causality in biology has to answer 2 main questions--which and how: letter to the editor. Am J Sports Med (2013) 1.06
Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials (2006) 1.04
Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res (2009) 1.03
Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease. J Alzheimers Dis (2011) 1.02
History, challenges and perspectives of cell microencapsulation. Trends Biotechnol (2004) 0.99
Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res (2004) 0.97
Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangers. Curr Alzheimer Res (2007) 0.97
Influence of implant length, diameter, and geometry on stress distribution: a finite element analysis. Int J Periodontics Restorative Dent (2010) 0.96
Biomaterials in cell microencapsulation. Adv Exp Med Biol (2010) 0.95
Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release (2011) 0.95
Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev (2010) 0.94
Short implants in maxillae and mandibles: a retrospective study with 1 to 8 years of follow-up. J Periodontol (2010) 0.93
Clinical outcome of immediately loaded dental implants bioactivated with plasma rich in growth factors: a 5-year retrospective study. J Periodontol (2008) 0.93
Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. BMC Neurol (2010) 0.93
Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm (2006) 0.92
Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approaches. Front Pharmacol (2012) 0.91
Bilateral sinus elevation evaluating plasma rich in growth factors technology: a report of five cases. Clin Implant Dent Relat Res (2010) 0.91
Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease. Neurobiol Dis (2009) 0.91
Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients. J Clin Pharmacol (2005) 0.91
Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. Mol Cell Neurosci (2010) 0.90
Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-β1-induced myodifferentiation. J Periodontol (2011) 0.89
Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis. Neurobiol Aging (2008) 0.89
The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials (2010) 0.89
Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. Acta Neuropathol (2009) 0.89
Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D. Trends Biotechnol (2012) 0.89
A preliminary approach to the repair of myocardial infarction using adipose tissue-derived stem cells encapsulated in magnetic resonance-labelled alginate microspheres in a porcine model. Eur J Pharm Biopharm (2012) 0.89
Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J Control Release (2009) 0.88
Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors. Ann Anat (2013) 0.88
Plasma rich in growth factors promotes bone tissue regeneration by stimulating proliferation, migration, and autocrine secretion in primary human osteoblasts. J Periodontol (2012) 0.87
Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy. Clin Pharmacokinet (2008) 0.86
A multicentre placebo-controlled randomised clinical trial of antibiotic prophylaxis for placement of single dental implants. Eur J Oral Implantol (2009) 0.86
In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies. Chemotherapy (2007) 0.85
Clinical evaluation of Tiny® 2.5- and 3.0-mm narrow-diameter implants as definitive implants in different clinical situations: a retrospective cohort study. Eur J Oral Implantol (2010) 0.85
Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration. J Clin Pharmacol (2005) 0.85
Techniques: new approaches to the delivery of biopharmaceuticals. Trends Pharmacol Sci (2004) 0.85
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiol Aging (2013) 0.85
Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells. Biomacromolecules (2013) 0.85
Five-year clinical evaluation of short dental implants placed in posterior areas: a retrospective study. J Periodontol (2008) 0.84
The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes. Diabetes Res Clin Pract (2011) 0.84
Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J Neurophysiol (2003) 0.84
The importance of understanding what is platelet-rich growth factor (PRGF) and what is not. J Shoulder Elbow Surg (2010) 0.84
The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: a histologic and histomorphometric study. J Biomed Mater Res A (2009) 0.84
Endogenous regenerative technology using plasma- and platelet-derived growth factors. J Control Release (2011) 0.84
Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg (2014) 0.83
Controlled ridge expansion using a two-stage split-crest technique with ultrasonic bone surgery. Implant Dent (2012) 0.83
Gelsolin restores A beta-induced alterations in choroid plexus epithelium. J Biomed Biotechnol (2010) 0.83
Neurogenic effects of β-amyloid in the choroid plexus epithelial cells in Alzheimer's disease. Cell Mol Life Sci (2013) 0.83
Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis. Gynecol Endocrinol (2013) 0.83
In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules. Biomacromolecules (2007) 0.82
Highlights and trends in cell encapsulation. Adv Exp Med Biol (2010) 0.82
PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer's disease. J Alzheimers Dis (2010) 0.82
Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. J Pharm Pharm Sci (2005) 0.82
Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci (2011) 0.82
Time-dependent release of growth factors from implant surfaces treated with plasma rich in growth factors. J Biomed Mater Res A (2012) 0.82
A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae. Vaccine (2011) 0.82
A biological therapy to osteoarthritis treatment using platelet-rich plasma. Expert Opin Biol Ther (2013) 0.82
Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int J Pharm (2007) 0.82
The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice. Exp Neurol (2009) 0.81
The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epithelium. BMC Neurosci (2011) 0.81
Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines. Vaccine (2011) 0.81